Abstract
Twenty-four patients, 19 with brain tumors and 5 with malignant melanomas, have been treated at the Kyoto University Reactor by boron neutron capture therapy (BNCT) in the past two years. The purpose of this paper is to summarize the seven cases we treated and to examine the most suitable conditions for patients, boron compounds, and irradiation modification for successful BNCT.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
H. Hatanaka, “Neutron Capture Therapy,” Nishimura Publishing Company, Niigata (1986).
Y. Yamamoto, T. Seko, H. Nakamura, H. Nemoto, et al., Synthesis of carboranes containing nucleoside bases: Unexpectedly high cytostatic and cytocidal toxicity toward cancer cells, J Chem Soc Chem Comm. 157–58 (1991).
M. Takagaki, Y. Oda, H.Kikuchi, T. Kobayashi, and K. Kanda, Gadolinium neutron capture therapy for brain tumors: Biological aspects, in: “Biological Aspects of Brain Tumors,” K. Tabuchi, ed., Springer Verlag (1991).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Oda, Y., Takagaki, M., Zhang, Z.H., Kikuchi, H., Kobayashi, T., Kanda, K. (1993). Clinical Experience with Bnct for Malignant Brain Tumors. In: Soloway, A.H., Barth, R.F., Carpenter, D.E. (eds) Advances in Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2978-1_137
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2978-1_137
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6296-8
Online ISBN: 978-1-4615-2978-1
eBook Packages: Springer Book Archive